Blog

RSS Feed
Posted by Michael Wonder on 09 Aug 2024

BioMarin announces updated strategy for Roctavian to focus on US, Germany and Italy

5 August 2024 - Strategic focus will reduce operating expenses with the goal of achieving Roctavian profitability by end of 2025. ...

Read more →
Posted by Michael Wonder on 24 Apr 2023

NICE collaborates with international partner agencies to streamline the confidential marking process

24 April 2023 - NICE, the Canadian Agency for Drugs and Technologies in Health and the US’s Institute for Clinical and ...

Read more →
Posted by Michael Wonder on 09 Sep 2017

Can a new value framework help ease friction over orphan drug prices?

7 September 2017 - America’s healthcare debate has stalled in Congress, but constructive dialogue and innovation are thriving in specialised ...

Read more →